Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.81 USD | +1.61% | +4.63% | +35.54% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.54% | 559M | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-12.92% | 32.81B | |
+53.49% | 25B | |
-16.51% | 15.29B | |
-8.27% | 12.93B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+5.54% | 8.98B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices : KeyBanc Adjusts Avid Bioservices' Price Target to $28 From $22, Reiterates Overweight Rating